tru Independence’s ContraFect Corporation CFRX Stock Holding History

tru Independence’s Portfolio CFRX Stock Details CFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-6	Closed	-$3	–	953
2020 Q2	$3	Hold	6	–	–	﹤0.01%	780
2020 Q1	$3	Buy	6 +5	+500%	+$3.41K	﹤0.01%	616
2019 Q4	$3K	Buy	+1	New	+$290	﹤0.01%	784

Other funds holding CFRX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

tru Independence's CFRX Position: Q3 2020 in Review

tru Independence sold out of ContraFect Corporation (CFRX) in Q3 2020, closing a stake of 6 shares — an estimated $3 sold.

tru Independence first reported a position in CFRX in Q4 2019 and held it in 3 quarters. The position peaked at $3K in Q4 2019. 60 funds tracked by Wall St. Rank hold CFRX as of Q3 2020.

tru Independence reported no remaining ContraFect Corporation position as of Q3 2020 after selling out during the quarter.
tru Independence sold 6 ContraFect Corporation shares in Q3 2020, an estimated $3.
tru Independence first reported a position in ContraFect Corporation in Q4 2019 and held it in 3 quarters.
tru Independence's ContraFect Corporation position peaked at $3K in Q4 2019.
60 funds tracked by Wall St. Rank held ContraFect Corporation as of Q3 2020.

Based on tru Independence's 13F filing for Q3 2020, filed 19 Nov 2020.